Efficacy News and Research

RSS

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

Immunotherapy -- harnessing T-cells to attack cancer cells in the body -- has given hope to patients who endure round after round of treatment, including chemotherapy, to little effect. For all of its promise, however, immunotherapy still benefits only a minority of patients -- a reality driving research in the field for ways to improve the relatively new approach.

30 Oct 2018

NEC and Transgene sign MOU for strategic collaboration aimed at treating solid cancers

NEC Corporation and Transgene today announced the signing of a Memorandum of Understanding for a strategic collaboration aimed at the treatment of solid cancers.

30 Oct 2018

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

Neuroene Therapeutics, a start-up company founded by mitochondrial biologist Sherine S. L. Chan, Ph.D. and medicinal chemist C. James Chou, Ph.D. of the Medical University of South Carolina, has received a $1.5 million NIH Phase II Small Business Innovation Research grant to optimize vitamin K analogues that could improve seizure control in patients with drug-resistant epilepsy.

29 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

New approach may lead to protective vaccines for immunocompromised patients

A study led by Som Nanjappa at the University of Illinois College of Veterinary Medicine identifies a cellular target that may improve efficacy in vaccines designed to protect immunocompromised individuals from potentially deadly opportunistic infections.

26 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

Easier treatment for age-related macular degeneration shows promise in clinical study

A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments. This represents a vast improvement over the typical regimen of nearly monthly eye injections.

26 Oct 2018

Raman microscopy can help detect cancer drug resistance

Biophysicists at Ruhr-Universität Bochum have demonstrated that Raman microscopy can be used to detect the resistance of tumor cells to cancer drugs.

26 Oct 2018

Quadrant Biosciences announces collaboration on research into treatment of ASD

Quadrant Biosciences, Inc., an emerging life science company based in Syracuse, N.Y., today announced its collaboration with the Autism Speaks® Autism Treatment Network and its university research partners on research into the treatment of autism spectrum disorder.

26 Oct 2018

Active ingredient in magic mushrooms could soon become a depression treatment

The active ingredient in magic mushrooms is psilocybin. Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushroom and is the reason behind the “high” provided by the magic mushrooms. Now, Psilocybin may soon achieve legal status to be used for treatment of difficult to treat depressive illness.

26 Oct 2018

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

Stress-induced mental disturbances are directly linked to abnormal glucose metabolism

Chronic stress is a well-known risk factor for the development of psychiatric illnesses including depression disorders. The brain requires a great deal of glucose, and stress is known to alter glucose metabolism.

24 Oct 2018

Study reveals unknown mechanism that protects tumor cells from NK cell-mediated cytotoxicity

Cancer cells have evolved multiple escape strategies to circumvent the body's immune defenses such as the attack by Natural Killer (NK) cells which normally swiftly kill abnormal cells by releasing cytotoxic products.

24 Oct 2018

Researchers identify a new way to prolong the circulation of cancer-fighting nanoparticles in the bloodstream

For a number of innovative and life-saving medical treatments, from organ replacements and skin grafts to cancer therapy and surgery, success often depends on slipping past or fending off the body's immune system.

24 Oct 2018

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

MWH Medical Pte Ltd, a leading homegrown medical group, and Siemens Healthineers are pleased to announce the launch of the first Asia Reference Center through their partnership.

From Siemens Healthineers 23 Oct 2018

Global HIV Vaccine Enterprise launches strategy to accelerate development of effective HIV vaccine

The Global HIV Vaccine Enterprise, hosted by the International AIDS Society, has launched a five-year strategy to accelerate the development of an effective vaccine to prevent HIV infection.

23 Oct 2018

Interweaving anxiety disorder associated with stuttering remains unrecognized

While stuttering impacts the lives of approximately 1-2 percent of adults and around 4-5 percent of children, the mental health impact of this disorder largely remains unrecognized.

23 Oct 2018

Drugs approved for breast cancer treatment are effective and well tolerated in men

There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two further studies to be reported at ESMO 2018.

23 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Efficacy News and Research

Scientists find ways to block nitration of amino acids to improve cancer immunotherapy

NEC and Transgene sign MOU for strategic collaboration aimed at treating solid cancers

Neuroene Therapeutics receives $1.5 million NIH grant to develop anti-seizure compound for epilepsy

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

New approach may lead to protective vaccines for immunocompromised patients

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

High-impact clinical trial results could affect kidney-related medical care

Easier treatment for age-related macular degeneration shows promise in clinical study

Raman microscopy can help detect cancer drug resistance

Quadrant Biosciences announces collaboration on research into treatment of ASD

Active ingredient in magic mushrooms could soon become a depression treatment

FDA approves new antiviral flu treatment

Stress-induced mental disturbances are directly linked to abnormal glucose metabolism

Study reveals unknown mechanism that protects tumor cells from NK cell-mediated cytotoxicity

Researchers identify a new way to prolong the circulation of cancer-fighting nanoparticles in the bloodstream

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

Global HIV Vaccine Enterprise launches strategy to accelerate development of effective HIV vaccine

Interweaving anxiety disorder associated with stuttering remains unrecognized

Drugs approved for breast cancer treatment are effective and well tolerated in men

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News